U.S. Fears For Patents On Next-Generation Drugs In India
Published: Mar 06, 2014
The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent. An Indian committee is reviewing up to a dozen patented drugs to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them, two senior government officials said last month.
Hey, check out all the research scientist jobs. Post your resume today!